| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.0041 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |